no Phase II or III trials published Most common AOD-9604 side effect / Injection-site reaction (redness, swelling) Most common reported MOTS-c side effect / Transient flushing and mild GI discomfort (anecdotal, not trial-confirmed) Growth hormone axis impact / AOD-9604 does not activate the GH receptor
Experience increased vitality, mental clarity, and overall well-being
At the 1 mg dose, subjects lost a mean of approximately 2.8 kg versus 0.8 kg in the placebo group over 12 weeks, a difference that reached statistical significance [1]
This rigorous analytical validation verifies the exact molecular composition, precise weight, and correct chemical structure while ensuring the total absence of residual synthesis reagents, heavy metals, or raw contaminants
Regular B12 injections may be particularly advantageous for individuals at risk of deficiency, promoting overall health and well-being